HSD17B12 and essential hypertension: Similarly, elevated levels of HSD17B12 were associated with decreased risks of essential hypertension (OR: 0.721; 95% CI: 0.629–0.826) and hypertension (OR: 0.728; 95% CI: 0.635–0.834) (Figure 3 and Tables S12–S17).